Butyric Acid

Butyric Acid

SCHEMBL1007031

CCCC(=O)O.CN(C)C

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.81
HDAC3 O15379 1/20 0.81
HDAC1 Q13547 1/20 0.81
HDAC2 Q92769 1/20 0.81
HDAC8 Q9BY41 1/20 0.81
AKR1B1 P15121 1/20 0.52
GPR84 Q9NQS5 7/20 0.50
PPARG P37231 7/20 0.50
PPARD Q03181 7/20 0.50
PPARA Q07869 7/20 0.50
HDAC11 Q96DB2 5/20 0.50
TSHR P16473 4/20 0.50
PTPN1 P18031 3/20 0.50
ALDH1A1 P00352 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL27852497 0.97 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL203760 0.97 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL28552593 0.94 FFAR3 (0.72) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL27792685 0.94 FFAR3 (0.72) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL26688 0.94
Butyric Acid SCHEMBL4446516 0.90 FFAR3 (1.00) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL1332215 0.90
Butyric Acid SCHEMBL8458708 0.90 FFAR3 (1.00) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL339305 0.90 FFAR3 (1.00) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL20678495 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104418825-A Method for purifying lipstatin UNIV PEKING FOUNDER GROUP CO 2015-03-18 CN claimed
CN-101654396-B Conversion of a multihydroxylated-aliphatic hydrocarbon or ester thereof to a chlorohydrin DOW GLOBAL TECHNOLOGIES INC US 2014-09-24 CN claimed
EP-2265617-B1 SOLVENTS BIONIQS LTD (GB) 2014-07-02 EP claimed
EP-2265617-A1 SOLVENTS Bioniqs Limited (GB) 2010-12-29 EP claimed
CN-101654396-A Conversion of a multihydroxylated-aliphatic hydrocarbon or ester thereof to a chlorohydrin DOW GLOBAL TECHNOLOGIES INC US 2010-02-24 CN claimed
WO-2009034329-A1 SOLVENTS BIONIQS LIMITED (GB) 2009-03-19 WO claimed
CN-1976886-A Conversion of multihydroxylated-aliphatic hydrocarbon or ester thereof to chlorohydrin DOW GLOBAL TECHNOLOGIES INC (US) 2007-06-06 CN claimed
CN-1125393-A Novel therapeutic delivery systems IMARX PHARMACEUTICAL CORP (US) 1996-06-26 CN claimed
EP-0360222-B1 PROCESS FOR PREPARING GAMMA-BUTYROBETAINE LONZA AG (CH) 1993-03-10 EP claimed
US-5087745-A PROCESS FOR THE PRODUCTION OF GAMMA-BUTYROBETAINE LONZA LTD. (CH) 1992-02-11 US claimed
US-20250242275-A1 APPARATUS AND METHOD FOR PROCESSING A BIOMASS MATERIAL BUSS-SMS-CANZLER GMBH (DE) 2025-07-31 US disclosed
US-20250145889-A1 METHOD FOR PROCESSING A BIOMASS MATERIAL PROIONIC GMBH (AT) 2025-05-08 US disclosed
CN-112286000-B Composition for forming silicon-containing resist underlayer film and pattern forming method 信越化学工业株式会社 2024-12-03 CN disclosed
CN-111856882-B Composition for forming silicon-containing resist underlayer film and pattern forming method 信越化学工业株式会社 2024-11-29 CN disclosed
CN-118804981-A Method for processing biomass material 普罗奥尼克股份有限公司 2024-10-18 CN disclosed
US-5717047-A Materials BIOCOMPATIBLES LIMITED (GB) 1998-02-10 US disclosed
CN-1125389-A Methods of preparing gas and gaseous precursor-filled microspheres IMARX PHARMACEUTICAL CORP (US) 1996-06-26 CN disclosed
US-5087745-A PROCESS FOR THE PRODUCTION OF GAMMA-BUTYROBETAINE LONZA LTD. (CH) 1992-02-11 US disclosed
US-5087745-A PROCESS FOR THE PRODUCTION OF GAMMA-BUTYROBETAINE LONZA LTD. (CH) 1992-02-11 US disclosed
CN-1048546-A Substituted imidazo-fused 6 unit heterocycle as angiotensin II antagonism medicine MERCK & CO INC (US) 1991-01-16 CN disclosed